{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:59:04Z","timestamp":1781222344613,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170827"],"award-info":[{"award-number":["82170827"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shanghai Municipality","award":["22ZR1450100"],"award-info":[{"award-number":["22ZR1450100"]}]},{"name":"Yangtze River Delta field regional cooperation projects of Shanghai Science and Technology Committee","award":["22002400600"],"award-info":[{"award-number":["22002400600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04087-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:30:28Z","timestamp":1751355028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["TyG-BMI as a superior predictor of MAFLD and pre-MAFLD in Chinese adults: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xinru","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lining","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongde","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"10290","key":"4087_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"suppl","key":"4087_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","volume":"29","author":"SK Han","year":"2023","unstructured":"Han SK, Baik SK, Kim MY. Non-alcoholic fatty liver disease: definition and subtypes. Clin Mol Hepatol. 2023;29(suppl):S5\u201316.","journal-title":"Clin Mol Hepatol"},{"issue":"10","key":"4087_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11894-023-00883-8","volume":"25","author":"YC Ilagan-Ying","year":"2023","unstructured":"Ilagan-Ying YC, Banini BA, Do A, Lam R, Lim JK. Screening, diagnosis, and staging of Non-Alcoholic fatty liver disease (NAFLD): application of society guidelines to clinical practice. Curr Gastroenterol Rep. 2023;25(10):213\u201324.","journal-title":"Curr Gastroenterol Rep"},{"key":"4087_CR4","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.molmet.2020.101143","volume":"50","author":"KK Bence","year":"2021","unstructured":"Bence KK, Birnbaum MJ. Metabolic drivers of non-alcoholic fatty liver disease. Mol Metab. 2021;50:101143.","journal-title":"Mol Metab"},{"issue":"Suppl","key":"4087_CR5","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","volume":"29","author":"C Gofton","year":"2023","unstructured":"Gofton C, Upendran Y, Zheng MH, George J. MAFLD: how is it different from NAFLD? Clin Mol Hepatol. 2023;29(Suppl):S17\u201331.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"4087_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2468-1253(23)00275-3","volume":"9","author":"JA Thomas","year":"2024","unstructured":"Thomas JA, Kendall BJ, El-Serag HB, Thrift AP, Macdonald GA. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol. 2024;9(2):159\u201369.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4087_CR7","doi-asserted-by":"publisher","first-page":"204201882211455","DOI":"10.1177\/20420188221145549","volume":"14","author":"RM Pipitone","year":"2023","unstructured":"Pipitone RM, Ciccioli C, Infantino G, La Mantia C, Parisi S, Tulone A, Pennisi G, Grimaudo S, Petta S. MAFLD: a multisystem disease. Ther Adv Endocrinol Metab. 2023;14:20420188221145549.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"Suppl 1","key":"4087_CR8","first-page":"S24","volume":"34","author":"N Katsiki","year":"2022","unstructured":"Katsiki N, Stoian AP, Rizzo M. Dietary patterns in non-alcoholic fatty liver disease (NAFLD): stay on the straight and narrow path! Clin Investig Arterioscler. 2022;34(Suppl 1):S24\u201331.","journal-title":"Clin Investig Arterioscler"},{"issue":"8","key":"4087_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.medcli.2022.06.017","volume":"159","author":"M Romero-G\u00f3mez","year":"2022","unstructured":"Romero-G\u00f3mez M. Non-alcoholic steatohepatitis. Med Clin (Barc). 2022;159(8):388\u201395.","journal-title":"Med Clin (Barc)"},{"issue":"6","key":"4087_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S2213-8587(21)00047-4","volume":"9","author":"Q Zeng","year":"2021","unstructured":"Zeng Q, Li N, Pan XF, Chen L, Pan A. Clinical management and treatment of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):393\u2013405.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"4087_CR11","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","volume":"30","author":"L Busetto","year":"2024","unstructured":"Busetto L, Dicker D, Fr\u00fchbeck G, Halford JCG, Sbraccia P, Yumuk V, Goossens GH. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024;30(9):2395\u20139.","journal-title":"Nat Med"},{"key":"4087_CR12","doi-asserted-by":"publisher","first-page":"3920196","DOI":"10.1155\/2020\/3920196","volume":"2020","author":"DM Tanase","year":"2020","unstructured":"Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, Ouatu A, Floria M. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). J Diabetes Res. 2020;2020:3920196.","journal-title":"J Diabetes Res."},{"issue":"1","key":"4087_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12944-022-01717-8","volume":"21","author":"M Kuang","year":"2022","unstructured":"Kuang M, Sheng G, Hu C, Lu S, Peng N, Zou Y. The value of combining the simple anthropometric obesity parameters, body mass index (BMI) and a body shape index (ABSI), to assess the risk of non-alcoholic fatty liver disease. Lipids Health Dis. 2022;21(1):104.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"4087_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.47391\/JPMA.22-63","volume":"72","author":"VK Ramdas Nayak","year":"2022","unstructured":"Ramdas Nayak VK, Satheesh P, Shenoy MT, Kalra S. Triglyceride glucose (TyG) index: A surrogate biomarker of insulin resistance. J Pak Med Assoc. 2022;72(5):986\u20138.","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"4087_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"key":"4087_CR16","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.2147\/DMSO.S433493","volume":"16","author":"Y Xing","year":"2023","unstructured":"Xing Y, Liu J, Gao Y, Zhu Y, Zhang Y, Ma H. Stronger associations of TyG index with diabetes than TyG-Obesity-Related parameters: more pronounced in young, Middle-Aged, and women. Diabetes Metab Syndr Obes. 2023;16:3795\u2013805.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"4087_CR17","doi-asserted-by":"publisher","first-page":"204201882211391","DOI":"10.1177\/20420188221139101","volume":"13","author":"F Grabherr","year":"2022","unstructured":"Grabherr F, Grander C, Effenberger M, Schw\u00e4rzler J, Tilg H. MAFLD: what 2 years of the redefinition of fatty liver disease has taught Us. Ther Adv Endocrinol Metab. 2022;13:20420188221139101.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"5","key":"4087_CR18","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264\u2013e12811264.","journal-title":"Gastroenterology"},{"issue":"5","key":"4087_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s12072-022-10408-6","volume":"16","author":"SK Sarin","year":"2022","unstructured":"Sarin SK, Eslam M, Fan JG, Lin HC, George J, Omata M. MAFLD, patient-centred care, and APASL. Hepatol Int. 2022;16(5):1032\u20134.","journal-title":"Hepatol Int"},{"key":"4087_CR20","doi-asserted-by":"publisher","first-page":"204201882311603","DOI":"10.1177\/20420188231160389","volume":"14","author":"B Norero","year":"2023","unstructured":"Norero B, Dufour JF. Should we undertake surveillance for HCC in patients with MAFLD? Ther Adv Endocrinol Metab. 2023;14:20420188231160389.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"4087_CR21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI134165","volume":"130","author":"GI Smith","year":"2020","unstructured":"Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW, Okunade AL, Patterson BW, Nyangau E, Field T, et al. Insulin resistance drives hepatic de Novo lipogenesis in nonalcoholic fatty liver disease. J Clin Invest. 2020;130(3):1453\u201360.","journal-title":"J Clin Invest"},{"issue":"2","key":"4087_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1172\/JCI200422422","volume":"114","author":"JD Browning","year":"2004","unstructured":"Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114(2):147\u201352.","journal-title":"J Clin Invest"},{"issue":"4","key":"4087_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"4087_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-022-01732-0","volume":"22","author":"Y Yang","year":"2023","unstructured":"Yang Y, Huang X, Wang Y, Leng L, Xu J, Feng L, Jiang S, Wang J, Yang Y, Pan G, et al. The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):2.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4087_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-022-01606-5","volume":"21","author":"X Wang","year":"2022","unstructured":"Wang X, Xu W, Song Q, Zhao Z, Meng X, Xia C, Xie Y, Yang C, Jin P, Wang F. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"4087_CR26","first-page":"375","volume":"16","author":"NMK Selvi","year":"2021","unstructured":"Selvi NMK, Nandhini S, Sakthivadivel V, Lokesh S, Srinivasan AR, Sumathi S. Association of Triglyceride-Glucose index (TyG index) with HbA1c and insulin resistance in type 2 diabetes mellitus. Maedica (Bucur). 2021;16(3):375\u201381.","journal-title":"Maedica (Bucur)"},{"key":"4087_CR27","doi-asserted-by":"publisher","first-page":"1083032","DOI":"10.3389\/fendo.2023.1083032","volume":"14","author":"H Peng","year":"2023","unstructured":"Peng H, Pan L, Ran S, Wang M, Huang S, Zhao M, Cao Z, Yao Z, Xu L, Yang Q, et al. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. Adults. Front Endocrinol (Lausanne). 2023;14:1083032.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4087_CR28","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1038\/s41598-024-84917-9","volume":"15","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Liu Z, Zhang J, Yang S, Liu L. Association between TyG related parameters and metabolic dysfunction associated fatty liver disease among nondiabetic individuals. Sci Rep. 2025;15(1):4566.","journal-title":"Sci Rep"},{"key":"4087_CR29","doi-asserted-by":"publisher","first-page":"1007171","DOI":"10.3389\/fendo.2022.1007171","volume":"13","author":"F Lei","year":"2022","unstructured":"Lei F, Qin JJ, Song X, Liu YM, Chen MM, Sun T, Huang X, Deng KQ, Zuo X, Yao D, et al. The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China. Front Endocrinol (Lausanne). 2022;13:1007171.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"4087_CR30","doi-asserted-by":"publisher","first-page":"102973","DOI":"10.1016\/j.dsx.2024.102973","volume":"18","author":"Y He","year":"2024","unstructured":"He Y, Yao N, Tian F, Liu L, Lin X, Chen X, Duan H, Jiang Y, Yu G, Song C, et al. Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in china: A cross-sectional study. Diabetes Metab Syndr. 2024;18(3):102973.","journal-title":"Diabetes Metab Syndr"},{"issue":"11","key":"4087_CR31","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1111\/dom.15238","volume":"25","author":"K Chen","year":"2023","unstructured":"Chen K, Shen Z, Gu W, Lyu Z, Qi X, Mu Y, Ning Y. Prevalence of obesity and associated complications in china: A cross-sectional, real-world study in 15.8 million adults. Diabetes Obes Metab. 2023;25(11):3390\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"4087_CR32","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.12998\/wjcc.v11.i6.1236","volume":"11","author":"M Martin-Grau","year":"2023","unstructured":"Martin-Grau M, Monleon D. Sex dimorphism and metabolic profiles in management of metabolic-associated fatty liver disease. World J Clin Cases. 2023;11(6):1236\u201344.","journal-title":"World J Clin Cases"},{"issue":"9","key":"4087_CR33","doi-asserted-by":"publisher","first-page":"e075413","DOI":"10.1136\/bmjopen-2023-075413","volume":"13","author":"R Yu","year":"2023","unstructured":"Yu R, Xie W, Peng H, Lu L, Yin S, Xu S, Hu Z, Peng XE. Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study. BMJ Open. 2023;13(9):e075413.","journal-title":"BMJ Open"},{"issue":"5","key":"4087_CR34","doi-asserted-by":"publisher","first-page":"e070189","DOI":"10.1136\/bmjopen-2022-070189","volume":"13","author":"M Chang","year":"2023","unstructured":"Chang M, Shao Z, Shen G. Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants. BMJ Open. 2023;13(5):e070189.","journal-title":"BMJ Open"},{"issue":"3","key":"4087_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/met.2020.0109","volume":"19","author":"ME Khamseh","year":"2021","unstructured":"Khamseh ME, Malek M, Abbasi R, Taheri H, Lahouti M, Alaei-Shahmiri F. Triglyceride glucose index and related parameters (Triglyceride glucose-Body mass index and triglyceride glucose-Waist Circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight\/obesity. Metab Syndr Relat Disord. 2021;19(3):167\u201373.","journal-title":"Metab Syndr Relat Disord"},{"issue":"9","key":"4087_CR36","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/liv.14548","volume":"40","author":"S Lin","year":"2020","unstructured":"Lin S, Huang J, Wang M, Kumar R, Liu Y, Liu S, Wu Y, Wang X, Zhu Y. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int. 2020;40(9):2082\u20139.","journal-title":"Liver Int"},{"issue":"6","key":"4087_CR37","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, et al. Accuracy of fibroscan controlled Attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"3","key":"4087_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"EASL-EASD-EASO Clinical","year":"2024","unstructured":"EASL-EASD-EASO Clinical. Practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542.","journal-title":"J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04087-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04087-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04087-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:30:30Z","timestamp":1751355030000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04087-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4087"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04087-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was granted by the research leading institute, Shanghai General Hospital affiliated to Shanghai Jiao Tong University, and all procedures were performed in compliance with the Helsinki Declaration of 1975, as revised in 2008. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"495"}}